Am J Psychiatry 1993; 150:819-821
Copyright © 1993 by American Psychiatric Association
Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder
TA Grady, TA Pigott, F L'Heureux, JL Hill, SE Bernstein and DL Murphy
Department of Psychiatry, Duke University Medical Center, Durham, NC 27710.
In a double-blind, crossover study, 13 fluoxetine-treated patients with
obsessive-compulsive disorder were given adjuvant buspirone and placebo for
4 weeks each. There were no significant differences between buspirone and
placebo in obsessive-compulsive, depressive, or anxiety symptoms.
This article has been cited by other articles:
|
|
|
|
 
K. J Craig and N. A Fineberg
OCD and anxiety: from afterthought to independence
J Psychopharmacol,
March 1, 2008;
22(2):
217 - 219.
[PDF]
|
|
|
|
|
|
|
J. H. Greist and J. W. Jefferson
Obsessive-Compulsive Disorder
Focus,
January 1, 2007;
5(3):
283 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Fineberg, T. M. Gale, and T. Sivakumaran
A review of antipsychotics in the treatment of obsessive compulsive disorder
J Psychopharmacol,
January 1, 2006;
20(1):
97 - 103.
[PDF]
|
|
|
|
|
|
|
D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
November 1, 2005;
19(6):
567 - 596.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Kaplan and E. Hollander
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
Focus,
July 1, 2004;
2(3):
454 - 461.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kaplan and E. Hollander
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
Psychiatr Serv,
August 1, 2003;
54(8):
1111 - 1118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Millan, S. Hjorth, R. Samanin, R. Schreiber, R. Jaffard, B. De Ladonchamps, S. Veiga, B. Goument, J.-L. Peglion, M. Spedding, et al.
S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties
J. Pharmacol. Exp. Ther.,
July 1, 1997;
282(1):
148 - 161.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. h. Greist, J. W. Jefferson, K. A. Kobak, D. J. Katzelnick, and R. C. Serlin
Efficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder: A Meta-analysis
Arch Gen Psychiatry,
January 1, 1995;
52(1):
53 - 60.
[Abstract]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1993
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
